Report for Lazarus P

General

Full name :

First name :

Mail :

Zip Code :

City :

Country :

Email :

Phone :

Fax :

Website :

Directory :

References (3)

Title : Cannabinoids and drug metabolizing enzymes: potential for drug-drug interactions and implications for drug safety and efficacy - Bardhi_2022_Expert.Rev.Clin.Pharmacol__
Author(s) : Bardhi K , Coates S , Watson CJW , Lazarus P
Ref : Expert Rev Clin Pharmacol , : , 2022
Abstract : Bardhi_2022_Expert.Rev.Clin.Pharmacol__
ESTHER : Bardhi_2022_Expert.Rev.Clin.Pharmacol__
PubMedSearch : Bardhi_2022_Expert.Rev.Clin.Pharmacol__
PubMedID: 36384377

Title : CHRNA5 risk variant predicts delayed smoking cessation and earlier lung cancer diagnosis--a meta-analysis - Chen_2015_J.Natl.Cancer.Inst_107_
Author(s) : Chen LS , Hung RJ , Baker T , Horton A , Culverhouse R , Saccone N , Cheng I , Deng B , Han Y , Hansen HM , Horsman J , Kim C , Lutz S , Rosenberger A , Aben KK , Andrew AS , Breslau N , Chang SC , Dieffenbach AK , Dienemann H , Frederiksen B , Han J , Hatsukami DK , Johnson EO , Pande M , Wrensch MR , McLaughlin J , Skaug V , van der Heijden HF , Wampfler J , Wenzlaff A , Woll P , Zienolddiny S , Bickeboller H , Brenner H , Duell EJ , Haugen A , Heinrich J , Hokanson JE , Hunter DJ , Kiemeney LA , Lazarus P , Le Marchand L , Liu G , Mayordomo J , Risch A , Schwartz AG , Teare D , Wu X , Wiencke JK , Yang P , Zhang ZF , Spitz MR , Kraft P , Amos CI , Bierut LJ
Ref : J Natl Cancer Inst , 107 : , 2015
Abstract : Chen_2015_J.Natl.Cancer.Inst_107_
ESTHER : Chen_2015_J.Natl.Cancer.Inst_107_
PubMedSearch : Chen_2015_J.Natl.Cancer.Inst_107_
PubMedID: 25873736

Title : Epoxide hydrolase genotype and orolaryngeal cancer risk: interaction with GSTM1 genotype - Park_2003_Oral.Oncol_39_483
Author(s) : Park JY , Schantz SP , Lazarus P
Ref : Oral Oncol , 39 :483 , 2003
Abstract : Park_2003_Oral.Oncol_39_483
ESTHER : Park_2003_Oral.Oncol_39_483
PubMedSearch : Park_2003_Oral.Oncol_39_483
PubMedID: 12747973